Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AR C124910XX

Known as: AR-C124910XX 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND The PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
Background. Therapy with aspirin and one of the platelet P2Y12 receptor inhibitors, preferably ticagrelor or prasugrel, is the… Expand
  • table 1
  • figure 1
  • figure 2
Highly Cited
2015
Highly Cited
2015
OBJECTIVES The goal of this study was to assess the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of escalating… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2015
2015
ObjectiveThe objective of this study was to assess the pharmacokinetic and pharmacodynamic behavior of ticagrelor administered… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2012
2012
PurposeTicagrelor, a reversibly binding oral P2Y12 receptor antagonist, is predominantly metabolized by cytochrome P450 3A and… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2012
2012
What is known and Objective:  Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist and has been approved in… Expand
2011
2011
Ticagrelor is the first direct acting reversibly binding oral platelet P2Y(12) receptor antagonist. The parent molecule and the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Highly Cited
2010
Highly Cited
2010
Ticagrelor [(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl) cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2010
Highly Cited
2010
Rapid and sensitive analytical methods using liquid chromatography with tandem mass spectrometry (LC/MS/MS) were developed for… Expand
Highly Cited
2009
Highly Cited
2009
  • R. Teng, K. Butler
  • European Journal of Clinical Pharmacology
  • 2009
  • Corpus ID: 23490203
PurposeTicagrelor (AZD6140) is the first reversibly binding oral P2Y12 receptor antagonist in development for reduction of… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2